Article metrics

Download PDFPDF

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

Statistics from

Online download statistics by month:

Online download statistics by month: February 2019 to December 2019

Feb 201914281413127
Mar 201923222753
Apr 201913212928
May 201911310637
Jun 2019565022
Jul 2019434119
Aug 20191754714
Sep 2019144357
Oct 20191544019
Nov 20191733917
Dec 20193012